Cite
HARVARD Citation
Cecchini, M. et al. (2021). A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer. Cancer. 127 (9), pp. 1417-1424. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cecchini, M. et al. (2021). A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer. Cancer. 127 (9), pp. 1417-1424. [Online].